Effects of Nintedanib in Subgroups Based on Combined Pulmonary Fibrosis and Emphysema (CPFE) Index at Baseline

被引：0

作者：

Cottin, V. ^{[1
]}

Ryerson, C. J. ^{[2
,3
]}

Flaherty, K. R. ^{[4
]}

Lee, J. S. ^{[5
]}

Corte, T. J. ^{[6
,7
]}

Schinzel, B. ^{[8
]}

Orsatti, L. ^{[8
]}

Quaresma, M. ^{[8
]}

Wells, A. U. ^{[9
,10
,11
]}

机构：

[1] Claude Bernard Univ Lyon 1, Natl Reference Ctr Rare Pulm Dis, Hosp Civils Lyon, Louis Pradel Hosp, Lyon, France

[2] Univ British Columbia, Dept Med, Vancouver, BC, Canada

[3] Univ British Columbia, Ctr Heart Lung Innovat, Vancouver, BC, Canada

[4] Univ Michigan, Ann Arbor, MI 48109 USA

[5] Univ Colorado Denver, Dept Med, Aurora, CO USA

[6] Royal Prince Alfred Hosp, Camperdown, NSW, Australia

[7] Univ Sydney, Sydney, NSW, Australia

[8] Boehringer Ingelheim Int GmbH, Ingelheim, Germany

[9] Royal Brompton Hosp, Natl Inst Hlth Res Resp Biomed Res Unit, London, England

[10] Harefield NHS Fdn Trust, London, England

[11] Imperial Coll, Natl Heart & Lung Inst, London, England

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A2752

引用

页数：2

共 50 条

[21] Nintedanib for the Idiopathic Pulmonary Fibrosis with Emphysema
Krome, Susanne
PNEUMOLOGIE, 2019, 73 (03):
[22] ACINAR VENTILATION HETEROGENEITY IS INCREASED IN IDIOPATHIC PULMONARY FIBROSIS (IPF) AND COMBINED PULMONARY FIBROSIS AND EMPHYSEMA (CPFE)
Ellis, M.
Prasad, J.
Westall, G.
Thompson, B.
RESPIROLOGY, 2016, 21 : 174 - 174
[23] Clinical Significance of Updated Pulmonary Hypertension Guidelines on Combined Pulmonary Fibrosis and Emphysema (CPFE)
Moore, J.
Rali, P.
Gayen, S.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
[24] Differences Of Pulmonary Function Test Between Of Combined Pulmonary Fibrosis And Emphysema(cpfe) And Idiopathic Pulmonary Fibrosis(ipf)
Kim, Y.
Shin, S.
Kyung, S.
Kang, S.
Lee, S.
Lee, S.
Park, J.
Jeong, S.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
[25] Evaluation of vessel remodelling in patients with Combined pulmonary fibrosis emphysema (CPFE) and idiopathic pulmonary fibrosis (IPF)
Calabrese, F.
Nannini, N.
Lunardi, F.
Balestro, E.
Rossi, E.
Marulli, G.
Loy, M.
Rea, F.
VIRCHOWS ARCHIV, 2011, 459 : S132 - S132
[26] Characterization of Idiopathic Pulmonary Fibrosis (IPF) and Combined Pulmonary Fibrosis and Emphysema (CPFE) using Respiratory Oscillometry
Wu, J.
Xu, J. J.
Nohra, C.
Vasileva, A.
Binnie, W. M.
Shapera, S.
Fisher, J.
Ryan, C.
Mcinnis, M.
Hantos, Z.
Chow, C.
EUROPEAN RESPIRATORY JOURNAL, 2022, 60
[27] Predictor Of Mortality And Clinical Characteristics In Patients With Combined Pulmonary Fibrosis And Emphysema (CPFE)
Kishaba, T.
Fukuyama, H.
Yoshida, K.
Noyama, M.
Kamata, A.
Yamashiro, S.
Tamaki, H.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
[28] Differences in FVC decline by extent of emphysema in patients with combined pulmonary fibrosis and emphysema (CPFE) syndrome
Cottin, Vincent
Hansell, David M.
Sverzellati, Nicola
Weycker, Derek
Antoniou, Katerina M.
Atwood, Mark
Oster, Gerry
Weber, Frank
Kirchgaessler, Klaus-Uwe
Collard, Harold R.
Wells, Athol U.
EUROPEAN RESPIRATORY JOURNAL, 2015, 46
[29] Relationship Between Systemic And Localized Inflammatory Protein Expression In Combined Pulmonary Fibrosis And Emphysema (cpfe), Interstitial Pulmonary Fibrosis, And Emphysema
Cornwell, W.
Kim, C.
Lastra, A. C.
Dass, C.
Bolla, S.
Wang, H.
Marchetti, N.
Rogers, T. J.
Criner, G. J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
[30] Effect of Nintedanib in Patients with Progressive Pulmonary Fibrosis in Subgroups with Differing Baseline Characteristics
Martin Kolb
Kevin R. Flaherty
Rafael S. Silva
Antje Prasse
Carlo Vancheri
Heiko Mueller
Kamila Sroka-Saidi
Athol U. Wells
Advances in Therapy, 2023, 40 : 5536 - 5546

← 1 2 3 4 5 →